Skip to main content
. 2001 Mar;158(3):977–986. doi: 10.1016/S0002-9440(10)64044-8

Table 1.

CTLA4Ig Interrupts Progression of Transplant Arteriosclerosis

Group n Vessel score Diseased vessel (%)
CTLA4Ig 30–120 6 0.39 ± 0.30* 16.32 ± 13.21*
CTLA4Ig 60–120 5 0.57 ± 0.35* 25.35 ± 12.76*
Control Ig 6 1.68 ± 0.81 55.93 ± 26.06
Isograft 7 0.14 ± 0.14* 2.78 ± 4.81*

Comparison of group versus control Ig-treated group. Values expressed as means ± SD.

*P < 0.001 using an analysis of variance with Bonferroni correction.